Meckel’s Diverticulum — Clinical Documentation Guide (2026)

🔍 Definition

Meckel's diverticulum is the most common congenital anomaly of the gastrointestinal tract, arising from incomplete obliteration of the vitelline (omphalomesenteric) duct during embryonic development. It is a true diverticulum — meaning it contains all layers of the small bowel wall (mucosa, submucosa, muscularis propria, and serosa) — distinguishing it from acquired or false diverticula. Per StatPearls (NIH/NCBI), it is classified under ICD-10-CM Q43.0: Meckel's diverticulum (displaced) (hypertrophic), which also includes the persistent omphalomesenteric duct and persistent vitelline duct. The code remains valid and unchanged for FY2026 per AAPC.

Unlike acquired colonic diverticulosis (K57.x), which involves herniation of only the mucosal and submucosal layers through a weakened muscle wall, Meckel's diverticulum is a congenital anomaly present from birth. It is located on the antimesenteric border of the ileum and is supplied by an anomalous branch of the superior mesenteric artery.

🗂️ Alternative Terminology

Meckel's diverticulum is known by several clinical, lay, and historical terms. Accurate recognition of these terms ensures correct ICD-10-CM assignment regardless of the terminology used in physician documentation.

🩺 Signs & Symptoms

The vast majority (approximately 98%) of individuals with Meckel's diverticulum remain entirely asymptomatic throughout their lives, with the anomaly discovered incidentally during imaging or surgery for other conditions. When symptoms do occur, they arise from complications. According to StatPearls (NIH/NCBI), the average age of symptomatic presentation is 2.5 years, though adults can present at any age.

Symptomatic Presentations by Age Group

• Children (< 2 years): Painless rectal bleeding is the hallmark — "currant jelly" or brick-colored stools resulting from acid-induced ulceration by ectopic gastric mucosa. Meckel's diverticulum accounts for approximately 50% of all lower GI bleeding in children under age 2.
• Older children and adolescents: Abdominal pain mimicking appendicitis (right lower quadrant), intussusception with the diverticulum as a lead point, or bowel obstruction from a fibrous band.
• Adults: Small bowel obstruction is the most common presentation; may also present with melena, occult GI bleeding, diverticulitis, or perforation.

Key Clinical Signs

• Painless or relatively painless rectal bleeding (hematochezia or melena)
• Signs of anemia (pallor, tachycardia, fatigue) — especially in pediatric patients
• Signs of acute bowel obstruction (distension, absence of bowel sounds, vomiting)
• Peritoneal signs if perforation or diverticulitis has occurred
• Right lower quadrant tenderness (may mimic appendicitis)
• Palpable abdominal mass when intussusception is present

🧭 Differential Diagnosis

Meckel's diverticulum is famously difficult to diagnose pre-operatively because its presentations mimic many other GI conditions. The differential varies significantly by age group and presenting complication.

📋 Clinical Indicators for Coders/CDI

These indicators help coders and CDI specialists recognize when Meckel's diverticulum should be coded or queried. Documentation of any of the following warrants investigation for Q43.0 or a related complication code.

🦴 Anatomy & Pathophysiology

Embryological Origin

During embryogenesis, the omphalomesenteric (vitelline) duct connects the yolk sac to the primitive midgut, providing nutrition until the placenta develops. By approximately the 7th week of gestation, this duct normally undergoes complete obliteration and separation from the intestine. Failure of complete involution produces a spectrum of anomalies ranging from a patent omphalomesenteric fistula (draining through the umbilicus) to a fibrous cord, omphalomesenteric cyst, or the most common remnant — Meckel's diverticulum, a blind-ending pouch on the antimesenteric border of the ileum. Per StatPearls (NIH/NCBI), the condition is congenital and present from birth regardless of when it is identified.

The “Rule of 2s” — CDI Mnemonic

The classic "Rule of 2s" summarizes the epidemiology of Meckel's diverticulum and serves as a CDI trigger phrase. When clinicians document "rule of 2s," it signals that Meckel's diverticulum is being considered or confirmed. Per the American College of Surgeons Case Reviews:

• 2% of the general population is affected
• 2% of those affected become symptomatic
• Symptoms typically present before age 2
• 2 times more common in males than females
• Located within 2 feet (60 cm) proximal to the ileocecal valve
• Typically 2 inches (5 cm) in length or less
• 2 types of ectopic mucosa possible: gastric or pancreatic

Pathophysiology of Complications

Approximately 15% of patients with Meckel's diverticulum have ectopic tissue within the diverticulum — most commonly gastric mucosa, which secretes acid not neutralized by pancreatic bicarbonate. This produces ulceration of the adjacent normal ileal mucosa, causing painless lower GI bleeding — the hallmark complication in children. As described in The British Journal of Radiology (PMC), additional mechanisms include:

• Bowel obstruction: Fibrous bands from the diverticulum to the umbilicus can cause internal herniation, volvulus, or adhesions. The diverticulum itself can also act as a lead point for intussusception (coded K56.1 with Q43.0).
• Meckel's diverticulitis: Inflammation of the diverticulum, clinically indistinguishable from acute appendicitis; can progress to perforation and peritonitis.
• Malignancy: Rare; carcinoid tumors or adenocarcinoma can arise in the diverticulum (code separately — C17.3 for Meckel's diverticulum malignant).

💊 Medication Impact / Treatment

Meckel's diverticulum is a structural/congenital anomaly; there is no pharmacological cure or primary medical management. However, several medication-related considerations are important for coders and CDI specialists:

Pre-operative / Diagnostic Enhancement

• Pentagastrin, cimetidine (H2 blocker), ranitidine, or glucagon: Administered prior to Meckel's radionuclide scan (CPT 78290) to enhance technetium-99m pertechnetate uptake by ectopic gastric mucosa and improve scan sensitivity. When documented, these agents support medical necessity for the nuclear scan.
• Technetium-99m pertechnetate: The radiopharmaceutical used in the Meckel's scan; its uptake is dependent on the presence of ectopic gastric mucosa, per Carelon Clinical Guidelines. A negative scan does not exclude Meckel's if no gastric mucosa is present.

Supportive / Perioperative Management

• IV fluid resuscitation and blood transfusion: For significant GI hemorrhage prior to surgery. Document blood product transfusion for accurate resource reporting and potential DRG impact.
• Proton pump inhibitors (PPIs) / antacids: May be used short-term to reduce acid-mediated ulceration pending surgical repair; not a definitive treatment.
• Broad-spectrum antibiotics: Administered perioperatively for surgical prophylaxis; document if used for concurrent diverticulitis or perforation (affects coding of the complication).
• Anticoagulants / antiplatelet agents: If the patient is on these medications, documentation of their impact on the GI bleeding episode is important for clinical management and coding of complicating factors.

Definitive treatment is always surgical — see Section 16 (Treatments) for full clinical detail.

Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.

← Back to All Clinical Documentation Guides